Mitchell E. Taub
Impact in
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 23
- Pharmacogenetics and Drug Metabolism 22
- Oncology 33
- Drug Transport and Resistance Mechanisms 33
- Co-authors
- Lalitha Podila (4 shared papers)Sven Frøkjær (8 shared papers)Thomas Ebner (5 shared papers)Maciej J. Zamek‐Gliszczynski (4 shared papers)Rucha S Sane (4 shared papers)Harma M. Ellens (4 shared papers)Bente Steffansen (7 shared papers)Wei‐Chiang Shen (5 shared papers)
- Journals
- Drug Metabolism and Disposition (17 papers)Pharmaceutical Research (5 papers)Journal of Pharmaceutical Sciences (4 papers)Clinical Pharmacology & Therapeutics (4 papers)International Journal of Pharmaceutics (3 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Mitchell E. Taub
58 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 80
- Oncology 1k
- Pharmacology 445
- Pharmaceutical Science 175
- Hepatology 55
- Neurology 35
Countries citing papers authored by Mitchell E. Taub
This map shows the geographic impact of Mitchell E. Taub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell E. Taub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell E. Taub more than expected).
Fields of papers citing papers by Mitchell E. Taub
This network shows the impact of papers produced by Mitchell E. Taub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell E. Taub. The network helps show where Mitchell E. Taub may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell E. Taub, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 185 | |
| 2 | 2013 | 168 | |
| 3 | 2013 | 134 | |
| 4 | 2015 | 119 | |
| 5 | 2005 | 109 | |
| 6 | 2016 | 70 | |
| 7 | 2012 | 69 | |
| 8 | 2011 | 63 | |
| 9 | 2013 | 63 | |
| 10 | 2015 | 61 | |
| 11 | 2001 | 60 | |
| 12 | 2002 | 59 | |
| 13 | 1992 | 55 | |
| 14 | 2020 | 46 | |
| 15 | 2018 | 41 | |
| 16 | 2013 | 37 | |
| 17 | 2014 | 32 | |
| 18 | 2014 | 30 | |
| 19 | 2017 | 30 | |
| 20 | 2020 | 27 |
About Mitchell E. Taub
Mitchell E. Taub is a scholar working on Pharmacology, Oncology, Pharmaceutical Science, Biochemistry and Hepatology, having authored 64 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (33 papers), Pharmacogenetics and Drug Metabolism (22 papers), Drug Solubulity and Delivery Systems (8 papers), Amino Acid Enzymes and Metabolism (4 papers), Advanced Drug Delivery Systems (4 papers), Nanoparticle-Based Drug Delivery (3 papers), Cellular transport and secretion (3 papers) and Hepatitis C virus research (2 papers). The work is most often cited by research in Oncology (1k citations), Pharmacology (445 citations), Pharmaceutical Science (175 citations), Hepatology (55 citations) and Neurology (35 citations). Mitchell E. Taub has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Lalitha Podila, Sven Frøkjær, Thomas Ebner, Maciej J. Zamek‐Gliszczynski, Rucha S Sane, Harma M. Ellens, Bente Steffansen, Wei‐Chiang Shen, Xiaoyan Chu and Naoki Ishiguro. Their work appears in journals such as Drug Metabolism and Disposition, Pharmaceutical Research, Journal of Pharmaceutical Sciences, Clinical Pharmacology & Therapeutics and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.